Stocks to Watch: Gemini Explorations, Inc. (OTCBB: GXPI), Credence Systems (NasdaqGS:CMOS), Advanced Cell Technology, Inc. (OTC BB:ACTC), GTx, Inc. (NasdaqGM:GTXI) , Turbine Truck Engines, Inc (OTC BB:TTEG)
Featured Stock: Gemini Explorations, Inc.
(OTCBB: GXPI)
Current Price (0.17)
http://www.wallstreetstockreview.com/
Michael Hill, President and CEO of Gemini Explorations, Inc.., is the Featured Guest in a New Audio Interview at SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements express or implied by such forward-looking statements. The forward-looking statements are subject to risks and uncertainties including, without limitation, changes in levels of competition, possible loss of customers, and the company's ability to attract and retain key personnel.
Contact:
Michael Hill
President
Gemini Explorations, Inc
http://www.geminiexploration.com/
email: info@geminiexploration.com
IR info: 1 877 700 1644
Source: http://www.smallcapvoice.com/
For an in-depth analyst report, please visit: http://www.wallstreetstockreview.com/
Credence Systems
(NasdaqGS:CMOS)
Current Price (2.50)
MILPITAS, CA--Nov 6, 2007 -- Credence Systems (NasdaqGS:CMOS - News), a leading provider of test and analytical solutions from design to production for the worldwide semiconductor industry, today announced major additions to its comprehensive range of integrated analytical tools designed to meet the complex challenges facing manufacturers of today's advanced 65nm, 45nm and beyond device technologies. The expanded product portfolio -- including the Ruby(TM) laser voltage probing system, the OptiFIB-IV® focused ion-beam (FIB) system, and the significantly enhanced Meridian(TM) and TriVision(TM) electrical failure analysis platforms -- will be showcased at the 33rd annual International Symposium for Testing and Failure Analysis (ISTFA 2007, Booth#425) to be held November 4-7 at the McEnery Convention Center, San Jose, California. Credence Systems Corporation is a leading provider of debug, characterization & ATE solutions for the global semiconductor industry. With a commitment to applying innovative technology to lower the cost-of-test, Credence delivers competitive cost & performance advantages to integrated device manufacturers (IDMs), wafer foundries, outsource assembly & test (OSAT) suppliers & fabless chip companies worldwide. A global, ISO 9001-certified company with a presence in 20 countries, Credence is headquartered in
Advanced Cell Technology, Inc.
(OTC BB:ACTC)
Current Price (0.28)
ORLANDO, Fla.--Nov. 7--Advanced Cell Technology, Inc. (OTCBB: ACTC - News) today announced that a controlled, randomized clinical trial led by Catholic Healthcare West’s Dr. Nabil Dib, M.D., M.Sc., F.A.C.C., using ACT’s myoblast therapy demonstrated marked improvement in heart failure symptoms after both six and twelve months. The trial also showed evidence that the hearts of the patients that received the therapy showed less cardiac remodeling (an increase in the size of the heart that signifies worsening of function) than did control patients. Dr. Dib presented the results of the trial today in a Late Breaking Clinical Trial Session at the American Heart Association’s annual meeting in
GTx, Inc.
(NasdaqGM:GTXI)
Current Price (16.35)
Turbine Truck Engines, Inc
(OTC BB:TTEG)
Current Price (.67)
DELAND, FLORIDA--Nov 6, 2007 -- Turbine Truck Engines, Inc. (OTC BB:TTEG.OB - News) announces today an alliance with Embry-Riddle Aeronautical University (Daytona, Florida campus) with the objective of further development of the (US Patented) 'Detonation Cycle Gas Turbine Engine' technology for manufacturing heavy-duty highway trucks. Turbine Truck Engines, Inc., a development stage company, owns an exclusive license for manufacturing and marketing heavy-duty highway truck engines in the
WallStreetStockReview.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering secu rities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b),WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive seventy two thousand dollars in 2006 and thirty six thousand in 2007 from Equity Alliance Intl. www.equityallianceir.com for a internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
